glutathione level mda mb 468 Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo MDA-MB-468 Luciferase Reporter Cell Line
MDA MB 468 Luciferase Reporter Cell Line AcceGen Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA MB 231 cells Cancer & Metabolism A novel chromen based small molecule induces apoptosis and modulates cellular response to triple negative breast cancer Scientific Reports Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



